Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD1
|
ENSG00000170365.10 | SMAD1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD1 | hg38_v1_chr4_+_145482761_145482820 | -0.54 | 2.1e-03 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_50968125 | 19.95 |
ENST00000594641.1
|
KLK6
|
kallikrein related peptidase 6 |
chr19_-_50968775 | 15.28 |
ENST00000391808.5
|
KLK6
|
kallikrein related peptidase 6 |
chr19_-_50953093 | 11.48 |
ENST00000593428.5
|
KLK5
|
kallikrein related peptidase 5 |
chr19_-_50952942 | 10.62 |
ENST00000594846.1
ENST00000336334.8 |
KLK5
|
kallikrein related peptidase 5 |
chr19_-_50953063 | 8.38 |
ENST00000391809.6
|
KLK5
|
kallikrein related peptidase 5 |
chr15_-_74212256 | 7.21 |
ENST00000416286.7
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
chr1_-_16978276 | 6.83 |
ENST00000375534.7
|
MFAP2
|
microfibril associated protein 2 |
chr19_+_6531018 | 6.70 |
ENST00000245817.5
|
TNFSF9
|
TNF superfamily member 9 |
chr15_-_74212219 | 6.60 |
ENST00000449139.6
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
chrX_-_48470163 | 6.57 |
ENST00000595796.5
|
SLC38A5
|
solute carrier family 38 member 5 |
chr4_-_56656507 | 6.04 |
ENST00000381255.7
ENST00000317745.11 ENST00000555760.6 ENST00000556614.6 |
HOPX
|
HOP homeobox |
chr7_-_1160144 | 5.74 |
ENST00000397083.6
ENST00000401903.5 ENST00000316495.8 |
ZFAND2A
|
zinc finger AN1-type containing 2A |
chr19_-_50969567 | 5.58 |
ENST00000310157.7
|
KLK6
|
kallikrein related peptidase 6 |
chr9_+_33795551 | 5.25 |
ENST00000379405.4
|
PRSS3
|
serine protease 3 |
chrX_-_48470243 | 5.22 |
ENST00000429543.2
ENST00000620913.5 |
SLC38A5
|
solute carrier family 38 member 5 |
chr10_+_86958557 | 4.96 |
ENST00000372017.4
ENST00000348795.8 |
SNCG
|
synuclein gamma |
chr19_+_35154715 | 4.95 |
ENST00000392218.6
ENST00000543307.5 ENST00000392219.7 ENST00000541435.6 ENST00000590686.5 ENST00000342879.7 ENST00000588699.5 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr22_+_31092447 | 4.60 |
ENST00000455608.5
|
SMTN
|
smoothelin |
chr1_-_153094521 | 4.41 |
ENST00000368750.8
|
SPRR2E
|
small proline rich protein 2E |
chr1_-_153057504 | 4.37 |
ENST00000392653.3
|
SPRR2A
|
small proline rich protein 2A |
chr19_-_43198079 | 4.34 |
ENST00000597374.5
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
chr19_-_42765657 | 4.20 |
ENST00000406636.7
ENST00000404209.8 ENST00000306511.5 |
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
chr4_-_56656448 | 4.13 |
ENST00000553379.6
|
HOPX
|
HOP homeobox |
chr19_-_11577632 | 4.03 |
ENST00000590420.1
ENST00000648477.1 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr1_-_153460644 | 4.02 |
ENST00000368723.4
|
S100A7
|
S100 calcium binding protein A7 |
chr2_-_112836702 | 3.91 |
ENST00000416750.1
ENST00000263341.7 ENST00000418817.5 |
IL1B
|
interleukin 1 beta |
chr5_+_136049513 | 3.87 |
ENST00000514554.5
|
TGFBI
|
transforming growth factor beta induced |
chr12_-_24903014 | 3.85 |
ENST00000539282.5
|
BCAT1
|
branched chain amino acid transaminase 1 |
chr9_+_33750669 | 3.77 |
ENST00000361005.10
ENST00000342836.9 ENST00000429677.8 |
PRSS3
|
serine protease 3 |
chr19_-_42528380 | 3.75 |
ENST00000403461.5
ENST00000352591.9 ENST00000358394.7 ENST00000403444.7 ENST00000161559.11 ENST00000599389.1 |
CEACAM1
|
CEA cell adhesion molecule 1 |
chr2_-_31138041 | 3.71 |
ENST00000324589.9
|
GALNT14
|
polypeptide N-acetylgalactosaminyltransferase 14 |
chr1_+_153416517 | 3.65 |
ENST00000368729.9
|
S100A7A
|
S100 calcium binding protein A7A |
chr6_+_151341680 | 3.60 |
ENST00000359755.5
|
AKAP12
|
A-kinase anchoring protein 12 |
chr2_-_24085186 | 3.55 |
ENST00000335934.8
|
TP53I3
|
tumor protein p53 inducible protein 3 |
chr9_+_128420812 | 3.50 |
ENST00000372838.9
|
CERCAM
|
cerebral endothelial cell adhesion molecule |
chr1_-_205422050 | 3.41 |
ENST00000367153.9
|
LEMD1
|
LEM domain containing 1 |
chr19_-_50968966 | 3.36 |
ENST00000376851.7
|
KLK6
|
kallikrein related peptidase 6 |
chr1_+_27879638 | 3.36 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr19_-_15934410 | 3.34 |
ENST00000326742.12
|
CYP4F11
|
cytochrome P450 family 4 subfamily F member 11 |
chr11_-_67674606 | 3.33 |
ENST00000674110.1
ENST00000349015.7 |
ALDH3B2
|
aldehyde dehydrogenase 3 family member B2 |
chr2_-_31414694 | 3.28 |
ENST00000379416.4
|
XDH
|
xanthine dehydrogenase |
chr5_-_150290093 | 3.27 |
ENST00000672479.1
|
CAMK2A
|
calcium/calmodulin dependent protein kinase II alpha |
chr11_+_118956289 | 3.26 |
ENST00000264031.3
|
UPK2
|
uroplakin 2 |
chr4_-_56681588 | 3.26 |
ENST00000554144.5
ENST00000381260.7 |
HOPX
|
HOP homeobox |
chr11_+_847197 | 3.18 |
ENST00000532375.5
ENST00000346501.8 |
TSPAN4
|
tetraspanin 4 |
chr1_-_28176665 | 3.18 |
ENST00000373857.8
|
PTAFR
|
platelet activating factor receptor |
chr1_-_153070840 | 3.12 |
ENST00000368755.2
|
SPRR2B
|
small proline rich protein 2B |
chr19_-_51034727 | 3.12 |
ENST00000525263.5
|
KLK12
|
kallikrein related peptidase 12 |
chr1_-_26354080 | 3.12 |
ENST00000308182.10
|
CRYBG2
|
crystallin beta-gamma domain containing 2 |
chr19_-_51034892 | 3.11 |
ENST00000319590.8
ENST00000250351.4 |
KLK12
|
kallikrein related peptidase 12 |
chr19_-_15934521 | 3.08 |
ENST00000402119.9
|
CYP4F11
|
cytochrome P450 family 4 subfamily F member 11 |
chr7_+_48089257 | 3.07 |
ENST00000436673.5
ENST00000395564.9 |
UPP1
|
uridine phosphorylase 1 |
chr2_-_215393126 | 3.06 |
ENST00000456923.5
|
FN1
|
fibronectin 1 |
chr4_-_10021490 | 3.04 |
ENST00000264784.8
|
SLC2A9
|
solute carrier family 2 member 9 |
chr4_+_8182066 | 3.03 |
ENST00000508641.2
|
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr7_+_142760398 | 3.00 |
ENST00000632998.1
|
PRSS2
|
serine protease 2 |
chr2_-_215138603 | 2.98 |
ENST00000272895.12
|
ABCA12
|
ATP binding cassette subfamily A member 12 |
chr20_+_35172046 | 2.97 |
ENST00000216968.5
|
PROCR
|
protein C receptor |
chr2_+_233195433 | 2.96 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase D |
chr22_-_18518161 | 2.95 |
ENST00000619998.1
|
GGTLC3
|
gamma-glutamyltransferase light chain family member 3 |
chr14_-_93955577 | 2.94 |
ENST00000555507.5
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr11_-_67674725 | 2.94 |
ENST00000525827.6
ENST00000673966.1 ENST00000673873.1 |
ALDH3B2
|
aldehyde dehydrogenase 3 family member B2 |
chr19_+_35154914 | 2.92 |
ENST00000423817.7
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr1_-_152414256 | 2.92 |
ENST00000271835.3
|
CRNN
|
cornulin |
chr16_+_8712943 | 2.87 |
ENST00000561870.5
ENST00000396600.6 |
ABAT
|
4-aminobutyrate aminotransferase |
chr13_-_20232191 | 2.84 |
ENST00000647243.1
|
GJB6
|
gap junction protein beta 6 |
chr14_-_24263162 | 2.84 |
ENST00000206765.11
ENST00000544573.5 |
TGM1
|
transglutaminase 1 |
chr1_+_20589044 | 2.82 |
ENST00000375071.4
|
CDA
|
cytidine deaminase |
chr12_-_119877270 | 2.82 |
ENST00000261833.11
ENST00000612548.4 |
CIT
|
citron rho-interacting serine/threonine kinase |
chr9_+_72577939 | 2.82 |
ENST00000645773.1
|
TMC1
|
transmembrane channel like 1 |
chr7_-_38330935 | 2.79 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
chr16_-_46621345 | 2.79 |
ENST00000303383.8
|
SHCBP1
|
SHC binding and spindle associated 1 |
chr20_+_63696643 | 2.78 |
ENST00000369996.3
|
TNFRSF6B
|
TNF receptor superfamily member 6b |
chr19_-_51020154 | 2.77 |
ENST00000391805.5
ENST00000599077.1 |
KLK10
|
kallikrein related peptidase 10 |
chr10_+_11823348 | 2.76 |
ENST00000277570.10
ENST00000622831.4 |
PROSER2
|
proline and serine rich 2 |
chr1_-_6419903 | 2.75 |
ENST00000377836.8
ENST00000487437.5 ENST00000489730.1 ENST00000377834.8 |
HES2
|
hes family bHLH transcription factor 2 |
chr4_-_56681288 | 2.75 |
ENST00000556376.6
ENST00000420433.6 |
HOPX
|
HOP homeobox |
chr17_+_64449037 | 2.74 |
ENST00000615220.4
ENST00000619286.5 ENST00000612535.4 ENST00000616498.4 |
MILR1
|
mast cell immunoglobulin like receptor 1 |
chr7_+_101127095 | 2.73 |
ENST00000223095.5
|
SERPINE1
|
serpin family E member 1 |
chr3_-_111595339 | 2.72 |
ENST00000317012.5
|
ZBED2
|
zinc finger BED-type containing 2 |
chr19_-_46495857 | 2.72 |
ENST00000599531.2
|
PNMA8B
|
PNMA family member 8B |
chr9_+_136952256 | 2.71 |
ENST00000371633.8
|
LCN12
|
lipocalin 12 |
chr11_-_125592448 | 2.70 |
ENST00000648911.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 |
chr16_-_55833085 | 2.70 |
ENST00000360526.8
|
CES1
|
carboxylesterase 1 |
chrX_-_107775951 | 2.68 |
ENST00000315660.8
ENST00000372384.6 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family member 3 |
chr19_-_55141889 | 2.67 |
ENST00000593194.5
|
TNNT1
|
troponin T1, slow skeletal type |
chr1_-_6485895 | 2.66 |
ENST00000675694.1
|
PLEKHG5
|
pleckstrin homology and RhoGEF domain containing G5 |
chr14_-_104953899 | 2.64 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
chr13_-_20232303 | 2.64 |
ENST00000400065.7
ENST00000643121.1 ENST00000647029.1 ENST00000643211.1 ENST00000400066.8 ENST00000644283.1 |
GJB6
|
gap junction protein beta 6 |
chr19_-_42937098 | 2.63 |
ENST00000623675.3
ENST00000446844.3 |
PSG7
|
pregnancy specific beta-1-glycoprotein 7 |
chr8_-_130386864 | 2.62 |
ENST00000521426.5
|
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
chr22_+_22644475 | 2.61 |
ENST00000618722.4
ENST00000652219.1 ENST00000480559.6 ENST00000448514.2 ENST00000652249.1 ENST00000651213.1 |
GGTLC2
|
gamma-glutamyltransferase light chain 2 |
chr16_+_88638569 | 2.60 |
ENST00000244241.5
|
IL17C
|
interleukin 17C |
chr20_-_57710539 | 2.56 |
ENST00000395816.7
ENST00000347215.8 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr22_-_37244417 | 2.56 |
ENST00000405484.5
ENST00000441619.5 ENST00000406508.5 |
RAC2
|
Rac family small GTPase 2 |
chr12_-_52452139 | 2.55 |
ENST00000252252.4
|
KRT6B
|
keratin 6B |
chr9_-_21305313 | 2.54 |
ENST00000610521.2
|
IFNA5
|
interferon alpha 5 |
chr19_+_2389761 | 2.53 |
ENST00000648592.1
|
TMPRSS9
|
transmembrane serine protease 9 |
chr19_-_55149193 | 2.52 |
ENST00000587758.5
ENST00000588981.6 ENST00000356783.9 ENST00000291901.12 ENST00000588426.5 ENST00000536926.5 ENST00000588147.5 |
TNNT1
|
troponin T1, slow skeletal type |
chr22_-_30299482 | 2.49 |
ENST00000434291.5
|
ENSG00000248751.6
|
novel protein |
chr15_-_52528821 | 2.48 |
ENST00000553916.5
|
MYO5A
|
myosin VA |
chr2_+_113117889 | 2.44 |
ENST00000361779.7
ENST00000259206.9 ENST00000354115.6 |
IL1RN
|
interleukin 1 receptor antagonist |
chr19_-_48513161 | 2.44 |
ENST00000673139.1
|
LMTK3
|
lemur tyrosine kinase 3 |
chr1_-_112956063 | 2.43 |
ENST00000538576.5
ENST00000369626.8 ENST00000458229.6 |
SLC16A1
|
solute carrier family 16 member 1 |
chr19_-_51020019 | 2.42 |
ENST00000309958.7
|
KLK10
|
kallikrein related peptidase 10 |
chr12_-_121039236 | 2.42 |
ENST00000257570.9
|
OASL
|
2'-5'-oligoadenylate synthetase like |
chr17_+_42458844 | 2.41 |
ENST00000393829.6
ENST00000537728.5 ENST00000343619.9 ENST00000264649.10 ENST00000585525.5 ENST00000544137.5 ENST00000589727.5 ENST00000587824.5 |
ATP6V0A1
|
ATPase H+ transporting V0 subunit a1 |
chr3_-_13880059 | 2.40 |
ENST00000285018.5
|
WNT7A
|
Wnt family member 7A |
chr19_-_50511146 | 2.38 |
ENST00000594350.1
ENST00000601423.5 |
JOSD2
|
Josephin domain containing 2 |
chr17_-_35795592 | 2.36 |
ENST00000615136.4
ENST00000605424.6 ENST00000612672.1 |
MMP28
|
matrix metallopeptidase 28 |
chr18_+_63777773 | 2.36 |
ENST00000447428.5
ENST00000546027.5 |
SERPINB7
|
serpin family B member 7 |
chr17_-_28576882 | 2.35 |
ENST00000395319.7
ENST00000581807.5 ENST00000226253.9 ENST00000584086.5 ENST00000395321.6 |
ALDOC
|
aldolase, fructose-bisphosphate C |
chr12_-_121039156 | 2.35 |
ENST00000339275.10
|
OASL
|
2'-5'-oligoadenylate synthetase like |
chr20_-_23986795 | 2.34 |
ENST00000286890.8
ENST00000278765.8 |
GGTLC1
|
gamma-glutamyltransferase light chain 1 |
chr1_+_65525641 | 2.33 |
ENST00000344610.12
ENST00000616738.4 |
LEPR
|
leptin receptor |
chr19_-_51034840 | 2.31 |
ENST00000529888.5
|
KLK12
|
kallikrein related peptidase 12 |
chr4_-_102345196 | 2.30 |
ENST00000683412.1
ENST00000682227.1 |
SLC39A8
|
solute carrier family 39 member 8 |
chr8_+_7539627 | 2.30 |
ENST00000533250.2
|
PRR23D1
|
proline rich 23 domain containing 1 |
chr2_+_233060295 | 2.28 |
ENST00000445964.6
|
INPP5D
|
inositol polyphosphate-5-phosphatase D |
chr2_+_112977998 | 2.27 |
ENST00000259205.5
ENST00000376489.6 |
IL36G
|
interleukin 36 gamma |
chr7_+_142770960 | 2.24 |
ENST00000632805.1
ENST00000633969.1 ENST00000539842.6 |
PRSS2
|
serine protease 2 |
chr21_-_43659460 | 2.24 |
ENST00000443485.1
ENST00000291560.7 |
HSF2BP
|
heat shock transcription factor 2 binding protein |
chr6_-_41163103 | 2.23 |
ENST00000373122.8
ENST00000373113.8 |
TREM2
|
triggering receptor expressed on myeloid cells 2 |
chr1_-_153041111 | 2.22 |
ENST00000360379.4
|
SPRR2D
|
small proline rich protein 2D |
chr5_+_151259793 | 2.21 |
ENST00000523004.1
|
GM2A
|
GM2 ganglioside activator |
chr2_+_101991953 | 2.21 |
ENST00000332549.8
|
IL1R2
|
interleukin 1 receptor type 2 |
chr2_-_31138429 | 2.21 |
ENST00000349752.10
|
GALNT14
|
polypeptide N-acetylgalactosaminyltransferase 14 |
chr7_-_24757926 | 2.20 |
ENST00000342947.9
ENST00000419307.6 |
GSDME
|
gasdermin E |
chr14_-_91253925 | 2.18 |
ENST00000531499.2
|
GPR68
|
G protein-coupled receptor 68 |
chr7_-_93890160 | 2.18 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr2_+_64453969 | 2.18 |
ENST00000464281.5
|
LGALSL
|
galectin like |
chr1_+_151060357 | 2.16 |
ENST00000368921.5
|
MLLT11
|
MLLT11 transcription factor 7 cofactor |
chr4_-_15938740 | 2.16 |
ENST00000382333.2
|
FGFBP1
|
fibroblast growth factor binding protein 1 |
chr12_-_121039204 | 2.15 |
ENST00000620239.5
|
OASL
|
2'-5'-oligoadenylate synthetase like |
chr9_-_21141832 | 2.15 |
ENST00000380229.4
|
IFNW1
|
interferon omega 1 |
chr7_+_142749465 | 2.15 |
ENST00000486171.5
ENST00000619214.4 ENST00000311737.12 |
PRSS1
|
serine protease 1 |
chr19_-_42855691 | 2.14 |
ENST00000401467.6
|
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
chr1_-_6261053 | 2.14 |
ENST00000377893.3
|
GPR153
|
G protein-coupled receptor 153 |
chr22_+_31093358 | 2.13 |
ENST00000404574.5
|
SMTN
|
smoothelin |
chr7_+_134527560 | 2.13 |
ENST00000359579.5
|
AKR1B10
|
aldo-keto reductase family 1 member B10 |
chr19_-_50514624 | 2.12 |
ENST00000601207.5
ENST00000598657.1 ENST00000376916.7 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr8_-_10839818 | 2.11 |
ENST00000554914.1
|
PINX1
|
PIN2 (TERF1) interacting telomerase inhibitor 1 |
chr22_-_37484505 | 2.10 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr11_-_111912871 | 2.10 |
ENST00000528628.5
|
CRYAB
|
crystallin alpha B |
chr17_-_41397600 | 2.10 |
ENST00000251645.3
|
KRT31
|
keratin 31 |
chr22_+_22646310 | 2.10 |
ENST00000417145.2
|
GGTLC2
|
gamma-glutamyltransferase light chain 2 |
chr9_+_122371036 | 2.09 |
ENST00000619306.5
ENST00000426608.6 ENST00000223423.8 |
PTGS1
|
prostaglandin-endoperoxide synthase 1 |
chr7_+_148339452 | 2.08 |
ENST00000463592.3
|
CNTNAP2
|
contactin associated protein 2 |
chr3_+_136819069 | 2.08 |
ENST00000393079.3
ENST00000446465.3 |
SLC35G2
|
solute carrier family 35 member G2 |
chr8_+_144148027 | 2.07 |
ENST00000423230.6
|
MROH1
|
maestro heat like repeat family member 1 |
chr2_+_90038848 | 2.05 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr4_-_56656304 | 2.05 |
ENST00000503639.7
|
HOPX
|
HOP homeobox |
chr13_-_39603123 | 2.04 |
ENST00000379589.4
|
LHFPL6
|
LHFPL tetraspan subfamily member 6 |
chr4_+_8199239 | 2.04 |
ENST00000245105.8
|
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr16_+_31472130 | 2.03 |
ENST00000394863.8
ENST00000565360.5 ENST00000361773.7 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
chr4_+_4386256 | 2.02 |
ENST00000397958.5
|
NSG1
|
neuronal vesicle trafficking associated 1 |
chr8_-_6877928 | 2.02 |
ENST00000297439.4
|
DEFB1
|
defensin beta 1 |
chr3_-_50303565 | 2.02 |
ENST00000266031.8
ENST00000395143.6 ENST00000457214.6 ENST00000447605.2 ENST00000395144.7 ENST00000418723.1 |
HYAL1
|
hyaluronidase 1 |
chr19_-_51342130 | 2.02 |
ENST00000335624.5
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like |
chr17_+_8039034 | 2.01 |
ENST00000572022.5
ENST00000380173.6 ENST00000380183.9 |
ALOX15B
|
arachidonate 15-lipoxygenase type B |
chr19_-_3801791 | 2.01 |
ENST00000590849.1
ENST00000395045.6 |
MATK
|
megakaryocyte-associated tyrosine kinase |
chr18_-_31102411 | 1.98 |
ENST00000251081.8
ENST00000280904.11 ENST00000682357.1 ENST00000648081.1 |
DSC2
|
desmocollin 2 |
chr12_-_57237090 | 1.96 |
ENST00000556732.1
|
NDUFA4L2
|
NDUFA4 mitochondrial complex associated like 2 |
chr4_+_8229170 | 1.95 |
ENST00000511002.6
|
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr5_-_150302884 | 1.95 |
ENST00000328668.8
|
ARSI
|
arylsulfatase family member I |
chr11_+_89926762 | 1.94 |
ENST00000526396.3
|
TRIM49D2
|
tripartite motif containing 49D2 |
chrX_-_107775740 | 1.92 |
ENST00000372383.9
|
TSC22D3
|
TSC22 domain family member 3 |
chr1_-_153113507 | 1.92 |
ENST00000468739.2
|
SPRR2F
|
small proline rich protein 2F |
chr16_-_55833186 | 1.92 |
ENST00000361503.8
ENST00000422046.6 |
CES1
|
carboxylesterase 1 |
chr1_+_150549734 | 1.92 |
ENST00000674043.1
ENST00000674058.1 |
ADAMTSL4
|
ADAMTS like 4 |
chr1_+_203682734 | 1.92 |
ENST00000341360.6
|
ATP2B4
|
ATPase plasma membrane Ca2+ transporting 4 |
chr10_-_96358989 | 1.92 |
ENST00000371172.8
|
OPALIN
|
oligodendrocytic myelin paranodal and inner loop protein |
chr14_-_106715166 | 1.91 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr1_-_6491664 | 1.90 |
ENST00000377728.8
ENST00000675093.1 |
PLEKHG5
|
pleckstrin homology and RhoGEF domain containing G5 |
chr1_+_156893678 | 1.90 |
ENST00000292357.8
ENST00000338302.7 ENST00000455314.5 |
PEAR1
|
platelet endothelial aggregation receptor 1 |
chr19_+_46229731 | 1.89 |
ENST00000437936.2
|
IGFL1
|
IGF like family member 1 |
chr19_-_50637939 | 1.89 |
ENST00000338916.8
|
SYT3
|
synaptotagmin 3 |
chrX_-_154653579 | 1.89 |
ENST00000247306.4
ENST00000369585.4 |
CTAG2
|
cancer/testis antigen 2 |
chr19_+_53882186 | 1.89 |
ENST00000682028.1
ENST00000683513.1 ENST00000263431.4 ENST00000419486.1 |
PRKCG
|
protein kinase C gamma |
chr1_-_204190324 | 1.89 |
ENST00000638118.1
|
REN
|
renin |
chr19_-_42879635 | 1.89 |
ENST00000595356.5
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1 |
chr19_+_48552159 | 1.88 |
ENST00000201586.7
|
SULT2B1
|
sulfotransferase family 2B member 1 |
chr2_+_113127588 | 1.88 |
ENST00000409930.4
|
IL1RN
|
interleukin 1 receptor antagonist |
chr11_-_111913195 | 1.88 |
ENST00000531198.5
ENST00000616970.5 ENST00000527899.6 |
CRYAB
|
crystallin alpha B |
chr11_+_35139162 | 1.87 |
ENST00000415148.6
ENST00000263398.11 ENST00000428726.8 ENST00000526669.6 ENST00000433892.6 ENST00000525211.6 ENST00000278386.10 ENST00000434472.6 ENST00000352818.8 ENST00000442151.6 |
CD44
|
CD44 molecule (Indian blood group) |
chr2_-_160200289 | 1.87 |
ENST00000409872.1
|
ITGB6
|
integrin subunit beta 6 |
chr19_+_15641280 | 1.87 |
ENST00000585846.1
|
CYP4F3
|
cytochrome P450 family 4 subfamily F member 3 |
chr5_+_151253171 | 1.86 |
ENST00000357164.4
|
GM2A
|
GM2 ganglioside activator |
chr1_-_6485941 | 1.86 |
ENST00000676287.1
ENST00000400913.6 |
PLEKHG5
|
pleckstrin homology and RhoGEF domain containing G5 |
chr14_+_64715677 | 1.86 |
ENST00000634379.2
|
PLEKHG3
|
pleckstrin homology and RhoGEF domain containing G3 |
chr20_+_25248036 | 1.86 |
ENST00000216962.9
|
PYGB
|
glycogen phosphorylase B |
chr12_-_119877300 | 1.86 |
ENST00000392521.7
|
CIT
|
citron rho-interacting serine/threonine kinase |
chr22_+_31081310 | 1.84 |
ENST00000426927.5
ENST00000482444.5 ENST00000440425.5 ENST00000333137.12 ENST00000358743.5 ENST00000347557.6 |
SMTN
|
smoothelin |
chr12_+_53097656 | 1.84 |
ENST00000301464.4
|
IGFBP6
|
insulin like growth factor binding protein 6 |
chr12_+_15546344 | 1.84 |
ENST00000674388.1
ENST00000542557.5 ENST00000445537.6 ENST00000544244.5 ENST00000442921.7 |
PTPRO
|
protein tyrosine phosphatase receptor type O |
chr6_+_31403553 | 1.84 |
ENST00000449934.7
ENST00000421350.1 |
MICA
|
MHC class I polypeptide-related sequence A |
chr4_+_4387078 | 1.84 |
ENST00000504171.1
|
NSG1
|
neuronal vesicle trafficking associated 1 |
chr12_+_40692413 | 1.84 |
ENST00000551295.7
ENST00000547702.5 ENST00000551424.5 |
CNTN1
|
contactin 1 |
chr11_-_107858777 | 1.83 |
ENST00000525815.6
|
SLC35F2
|
solute carrier family 35 member F2 |
chr16_+_3065297 | 1.83 |
ENST00000325568.9
|
IL32
|
interleukin 32 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 30.5 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
3.0 | 17.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
2.6 | 7.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
2.4 | 45.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
2.1 | 8.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
1.9 | 5.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
1.8 | 7.0 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.6 | 6.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.5 | 4.5 | GO:0046108 | uridine metabolic process(GO:0046108) |
1.5 | 3.0 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
1.4 | 4.3 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
1.3 | 3.8 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
1.2 | 4.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
1.2 | 1.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.2 | 4.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
1.1 | 3.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.1 | 3.2 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.1 | 3.2 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.1 | 7.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.1 | 4.2 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
1.0 | 3.0 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.9 | 2.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.9 | 3.8 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.9 | 4.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.8 | 15.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.8 | 6.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.8 | 12.3 | GO:0015816 | glycine transport(GO:0015816) |
0.8 | 4.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 7.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 2.3 | GO:0002665 | negative regulation of T cell tolerance induction(GO:0002665) negative regulation of T cell anergy(GO:0002668) negative regulation of lymphocyte anergy(GO:0002912) regulation of lymphotoxin A production(GO:0032681) positive regulation of lymphotoxin A production(GO:0032761) regulation of lymphotoxin A biosynthetic process(GO:0043016) positive regulation of lymphotoxin A biosynthetic process(GO:0043017) |
0.8 | 3.9 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.8 | 4.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.7 | 3.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 1.5 | GO:0072679 | thymocyte migration(GO:0072679) |
0.7 | 3.7 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.7 | 2.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.7 | 2.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.7 | 2.1 | GO:0016488 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
0.7 | 17.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.7 | 6.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.7 | 3.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.6 | 5.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 5.8 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.6 | 3.1 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.6 | 6.8 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.6 | 3.1 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.6 | 2.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.6 | 2.4 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.6 | 1.2 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.6 | 5.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.6 | 1.8 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.6 | 4.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.6 | 2.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.6 | 1.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.6 | 2.3 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.6 | 1.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.6 | 2.8 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.6 | 2.2 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.6 | 2.2 | GO:0032903 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.6 | 7.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.5 | 1.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.5 | 1.6 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.5 | 3.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.5 | 1.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.5 | 1.6 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.5 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.5 | 2.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.5 | 3.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.5 | 5.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 5.7 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.5 | 1.5 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.5 | 2.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 1.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 1.5 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.5 | 4.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.5 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) |
0.5 | 1.9 | GO:0036269 | swimming behavior(GO:0036269) |
0.5 | 0.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.5 | 1.9 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.5 | 2.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 1.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 10.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.5 | 1.8 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.5 | 0.9 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 2.7 | GO:0006196 | AMP catabolic process(GO:0006196) adenosine biosynthetic process(GO:0046086) |
0.5 | 7.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.5 | 1.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.5 | 1.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.5 | 1.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.4 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 5.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 4.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 2.2 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 0.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 2.5 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.4 | 1.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 3.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 1.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.4 | 1.2 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 1.2 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
0.4 | 1.6 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.4 | 2.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.4 | 0.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.4 | 0.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.6 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.4 | 2.0 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.4 | 0.4 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.4 | 2.3 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.4 | 1.5 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.4 | 1.9 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 1.9 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
0.4 | 6.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.4 | 4.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.4 | 1.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 1.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 1.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 1.5 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.4 | 3.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 1.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 2.2 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.4 | 0.7 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.4 | 1.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 1.1 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.4 | 1.1 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.4 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 2.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 2.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.3 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 0.3 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.7 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 1.0 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) regulation of chromatin silencing at telomere(GO:0031938) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.3 | 2.0 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 1.0 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.3 | 45.0 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.3 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.3 | 2.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 2.3 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.3 | 2.3 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
0.3 | 4.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 3.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 1.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 4.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 2.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 1.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.3 | 2.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 5.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 0.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 0.9 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.3 | 1.2 | GO:0097021 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
0.3 | 0.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.3 | 2.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.3 | 1.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 2.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 0.9 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.3 | 2.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.3 | 2.1 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.3 | 0.9 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.3 | 1.8 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.3 | 0.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.3 | 1.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.3 | 0.9 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 0.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.3 | 1.2 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.3 | 1.5 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.3 | 5.6 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.3 | 0.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 0.9 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.3 | 1.2 | GO:0035803 | egg coat formation(GO:0035803) |
0.3 | 1.7 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.3 | 7.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.6 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.3 | 5.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 0.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.3 | 2.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 3.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.9 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.3 | 1.1 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 4.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 5.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.8 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.3 | 1.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.3 | 4.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.3 | 0.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.3 | 0.8 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 4.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 2.9 | GO:0015820 | leucine transport(GO:0015820) |
0.3 | 1.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 3.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 1.0 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.3 | 1.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 1.6 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.3 | 0.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 0.5 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.3 | 1.0 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.3 | 2.6 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.3 | 1.3 | GO:1903412 | response to bile acid(GO:1903412) |
0.3 | 1.8 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 1.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 1.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 0.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 0.5 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.3 | 1.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.2 | 0.2 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
0.2 | 2.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.7 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.2 | 0.7 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.2 | 2.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 1.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 2.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 1.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 1.0 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.2 | 1.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 3.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 2.9 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.5 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.7 | GO:0060366 | subpallium cell proliferation in forebrain(GO:0022012) lateral ganglionic eminence cell proliferation(GO:0022018) lambdoid suture morphogenesis(GO:0060366) sagittal suture morphogenesis(GO:0060367) anterior semicircular canal development(GO:0060873) lateral semicircular canal development(GO:0060875) |
0.2 | 0.7 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.2 | 0.7 | GO:0030047 | actin modification(GO:0030047) |
0.2 | 9.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 1.4 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.2 | 3.1 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.9 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.2 | 0.7 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.2 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 1.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 0.7 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 1.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 1.4 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 0.7 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
0.2 | 1.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 2.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 0.4 | GO:0030806 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 0.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.9 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 0.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 1.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 0.9 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 1.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.2 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
0.2 | 6.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 3.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 1.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.6 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.2 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 3.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 2.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 6.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.6 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
0.2 | 0.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 0.4 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.2 | 2.7 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 0.8 | GO:0003285 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) |
0.2 | 0.4 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.2 | 1.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.8 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.2 | 0.4 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 1.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.4 | GO:0009631 | cold acclimation(GO:0009631) |
0.2 | 1.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.0 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 4.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.2 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 1.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.2 | 0.8 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
0.2 | 0.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 1.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 3.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 2.8 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.2 | 1.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 1.4 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 0.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 1.7 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 6.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.2 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 4.7 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 0.2 | GO:0071043 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) CUT catabolic process(GO:0071034) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) CUT metabolic process(GO:0071043) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.2 | 0.8 | GO:0061360 | optic nerve formation(GO:0021634) regulation of metanephros size(GO:0035566) optic chiasma development(GO:0061360) positive regulation of metanephric glomerulus development(GO:0072300) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.2 | 1.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.6 | GO:1903526 | regulation of membrane tubulation(GO:1903525) negative regulation of membrane tubulation(GO:1903526) |
0.2 | 3.0 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.7 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.9 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.2 | 0.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 0.7 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.2 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 7.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.8 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 2.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 6.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 2.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 1.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.2 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 4.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 1.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 2.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 1.0 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.2 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.2 | 1.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.3 | GO:2000077 | negative regulation of type B pancreatic cell development(GO:2000077) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 2.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.7 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 3.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 0.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 2.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.5 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 1.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 7.8 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.2 | 2.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.2 | 3.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 1.7 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 1.0 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 0.7 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 1.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 0.3 | GO:2000407 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.2 | 0.5 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.2 | 1.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 2.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.3 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.2 | 0.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 4.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 1.0 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.2 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 0.8 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 2.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 0.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.2 | 0.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.2 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
0.2 | 1.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.2 | 4.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.2 | 0.5 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.2 | 0.8 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 2.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 1.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.5 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.2 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 2.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 1.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.4 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 2.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.6 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.4 | GO:1904640 | response to methionine(GO:1904640) |
0.1 | 1.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 1.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 1.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 1.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.1 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.1 | 0.1 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.1 | 0.8 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 1.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.4 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 1.7 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
0.1 | 0.6 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) negative regulation of hair follicle maturation(GO:0048817) |
0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 1.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 3.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.4 | GO:0035565 | regulation of pronephros size(GO:0035565) |
0.1 | 0.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.1 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.3 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.5 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 1.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.5 | GO:0072309 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 1.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.1 | 0.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 1.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.1 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 0.9 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.1 | 0.1 | GO:0043380 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
0.1 | 0.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.4 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.1 | 6.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 1.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 6.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.4 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.4 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 0.5 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 0.1 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.0 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 2.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0099640 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) axo-dendritic protein transport(GO:0099640) |
0.1 | 0.5 | GO:0032241 | snRNA export from nucleus(GO:0006408) positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.1 | 0.7 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.8 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.7 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.1 | 0.5 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.6 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.1 | 0.9 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 1.0 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 1.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 2.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.8 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 1.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.1 | 0.3 | GO:0010932 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 4.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.5 | GO:0007497 | posterior midgut development(GO:0007497) enteric smooth muscle cell differentiation(GO:0035645) |
0.1 | 1.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 1.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0032597 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
0.1 | 0.3 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.1 | 2.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 1.1 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.1 | 1.2 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.3 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 0.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.4 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.4 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.5 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.1 | 2.7 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 0.3 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 2.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.1 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 1.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 3.0 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.8 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.1 | 0.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.1 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 1.7 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 1.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.7 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 1.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 2.0 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 1.3 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.1 | 0.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 1.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 1.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0021707 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 3.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 1.1 | GO:0061744 | motor behavior(GO:0061744) |
0.1 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 2.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.3 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.8 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.3 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.1 | 0.3 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.1 | 1.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 1.5 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.1 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.6 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.5 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.2 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.1 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 1.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.2 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.1 | 1.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.7 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.3 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.4 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 1.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.1 | 0.5 | GO:1901908 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.2 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.1 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 0.3 | GO:0048058 | compound eye corneal lens development(GO:0048058) |
0.1 | 0.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.8 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.2 | GO:1903238 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.1 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.1 | 3.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.2 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.9 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.2 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.1 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 1.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 0.3 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
0.1 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.5 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.8 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.1 | 0.5 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 0.2 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.4 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.1 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.4 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.1 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.1 | 3.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 5.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.3 | GO:1900276 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 2.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 2.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) nitric oxide homeostasis(GO:0033484) |
0.1 | 1.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.3 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.2 | GO:1902462 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.8 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.4 | GO:0015942 | formate metabolic process(GO:0015942) |
0.1 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.4 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 10.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 1.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 2.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 1.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 8.5 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.1 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 1.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 4.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.8 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.4 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.5 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 1.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 2.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.5 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.5 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.6 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.2 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.1 | 0.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 2.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.8 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.2 | GO:0035570 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.5 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.2 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
0.1 | 0.4 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.2 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 4.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
0.1 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 1.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.2 | GO:1901355 | response to rapamycin(GO:1901355) |
0.1 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0060578 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) endodermal digestive tract morphogenesis(GO:0061031) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 2.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.1 | 0.9 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 4.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.5 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.1 | 0.3 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 1.5 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.1 | GO:0060026 | convergent extension(GO:0060026) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.5 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 4.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 1.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.5 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.2 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.1 | 1.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.1 | 1.6 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 2.1 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.7 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.3 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 0.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.3 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.1 | 0.2 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 2.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.0 | 0.2 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
0.0 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.5 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:1904761 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
0.0 | 0.2 | GO:0051414 | response to cortisol(GO:0051414) |
0.0 | 1.3 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.0 | 1.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 7.4 | GO:0007565 | female pregnancy(GO:0007565) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.0 | 0.2 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.0 | 0.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 3.4 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.0 | 1.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0032898 | neurotrophin production(GO:0032898) regulation of neurotrophin production(GO:0032899) |
0.0 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 2.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.0 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.0 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 2.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.4 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.0 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) |
0.0 | 0.3 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 1.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.5 | GO:0016102 | diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 7.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.0 | 1.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.2 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.0 | 0.8 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 1.7 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 1.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 1.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.9 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.0 | 0.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.4 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.5 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 1.8 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 3.0 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.4 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 0.1 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
0.0 | 0.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.3 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
0.0 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 1.6 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.0 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 1.9 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.3 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.0 | 0.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.6 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.3 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.0 | 2.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.2 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.9 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.1 | GO:0015847 | putrescine transport(GO:0015847) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.4 | GO:0000732 | strand displacement(GO:0000732) |
0.0 | 2.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0070378 | regulation of ERK5 cascade(GO:0070376) positive regulation of ERK5 cascade(GO:0070378) |
0.0 | 0.4 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 0.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.3 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.3 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
0.0 | 0.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.4 | GO:0061615 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.0 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.5 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) histamine transport(GO:0051608) |
0.0 | 1.3 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 1.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 2.3 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.0 | 0.6 | GO:0006026 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.0 | 0.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 1.2 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.0 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) regulation of cytokine activity(GO:0060300) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
0.0 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 1.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 1.5 | GO:0051592 | response to calcium ion(GO:0051592) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.3 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.8 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.0 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
0.0 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.5 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.1 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.5 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.5 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 1.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.5 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.2 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0060324 | face development(GO:0060324) |
0.0 | 0.0 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.0 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.1 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 33.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.2 | 5.0 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
1.2 | 4.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
1.1 | 4.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.0 | 3.0 | GO:0032127 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.8 | 2.3 | GO:0071754 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
0.7 | 2.2 | GO:1990742 | microvesicle(GO:1990742) |
0.7 | 2.0 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.7 | 7.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.6 | 6.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.6 | 13.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.5 | 2.9 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 4.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.2 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 23.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 0.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.4 | 6.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 3.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.4 | 1.1 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
0.4 | 1.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 9.2 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 0.3 | GO:0030849 | autosome(GO:0030849) |
0.3 | 4.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.0 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 1.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.3 | 1.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 5.7 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 1.6 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 1.6 | GO:1990031 | pinceau fiber(GO:1990031) |
0.3 | 1.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.3 | 1.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.3 | 5.6 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 10.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 2.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 0.3 | GO:0005816 | spindle pole body(GO:0005816) |
0.3 | 2.5 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 1.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 4.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 1.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 2.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 2.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.7 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.2 | 5.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.7 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.2 | 1.6 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 2.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 2.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.2 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.2 | 0.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.2 | 2.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.2 | 2.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.4 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
0.2 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.8 | GO:1990879 | CST complex(GO:1990879) |
0.2 | 2.8 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 1.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 2.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.5 | GO:0097179 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) protease inhibitor complex(GO:0097179) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.2 | 4.9 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 0.9 | GO:0045160 | myosin I complex(GO:0045160) |
0.2 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 2.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.3 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.2 | 1.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 2.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.5 | GO:0016938 | kinesin I complex(GO:0016938) |
0.2 | 3.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.2 | 0.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 1.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 1.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 3.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 6.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.9 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.4 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 2.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.4 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
0.1 | 3.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 2.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 0.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 4.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 1.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 2.4 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 10.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.2 | GO:0032059 | bleb(GO:0032059) |
0.1 | 1.5 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.5 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.1 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 1.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 1.0 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.8 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.3 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.1 | 1.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 4.2 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.1 | 4.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.1 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 2.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 2.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 10.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 11.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 1.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 8.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 9.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 2.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.1 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.8 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 7.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.1 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 2.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 1.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 51.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 2.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.3 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 4.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.3 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 13.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 1.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.7 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 3.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 2.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 1.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.7 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 10.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.1 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 92.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.0 | 0.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 1.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 6.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.7 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 3.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 1.7 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 1.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.2 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 2.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.3 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 9.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.0 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.0 | 0.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0071920 | cleavage body(GO:0071920) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 32.6 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.0 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 2.1 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
1.7 | 5.0 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
1.5 | 4.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.5 | 4.5 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
1.2 | 4.8 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
1.2 | 6.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.1 | 3.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
1.1 | 5.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
1.0 | 3.1 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
1.0 | 11.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.9 | 4.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.9 | 2.6 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.8 | 15.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.8 | 3.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.8 | 3.3 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.8 | 3.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.8 | 2.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.8 | 3.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.8 | 3.9 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.8 | 6.8 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 5.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.7 | 11.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 5.8 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.7 | 7.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 2.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.7 | 4.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 2.0 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.7 | 5.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.7 | 2.0 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.6 | 1.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.6 | 2.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 2.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 2.3 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
0.6 | 9.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.6 | 2.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 1.7 | GO:0036219 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
0.6 | 1.7 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.6 | 2.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.6 | 1.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.5 | 3.3 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.5 | 1.6 | GO:0008431 | vitamin E binding(GO:0008431) |
0.5 | 7.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.5 | 10.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 2.1 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.5 | 2.0 | GO:0050421 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.5 | 1.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.5 | 3.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 1.5 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.5 | 1.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 1.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 1.4 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
0.5 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 1.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 1.4 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.5 | 1.8 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.5 | 1.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 0.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.4 | 2.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 2.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.4 | 2.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.4 | 1.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 0.4 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.4 | 1.3 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
0.4 | 2.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 2.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.3 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
0.4 | 0.4 | GO:1903135 | cupric ion binding(GO:1903135) |
0.4 | 3.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 1.2 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.4 | 2.4 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 2.0 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.4 | 128.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 1.2 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
0.4 | 6.6 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 1.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.4 | 4.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 1.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 7.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 0.7 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 5.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.1 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.4 | 1.1 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.4 | 1.5 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.4 | 3.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 5.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 1.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.4 | 3.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 4.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 3.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.8 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.3 | 1.0 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 0.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 1.0 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.3 | 7.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.3 | 2.0 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.3 | 1.7 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.3 | 3.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 3.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.6 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.3 | 2.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 1.0 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.3 | 1.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 2.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 3.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.6 | GO:0017129 | triglyceride binding(GO:0017129) |
0.3 | 1.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 1.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 5.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 1.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 5.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 2.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 1.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 0.9 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.3 | 4.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 0.3 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.3 | 2.9 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 2.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 0.3 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.3 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 3.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 2.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 4.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 11.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.6 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.3 | 3.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 3.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 1.6 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 3.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 1.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.3 | 12.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.3 | 1.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 1.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 2.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.2 | 1.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 2.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 1.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 1.0 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.9 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 1.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.2 | 1.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 3.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) cholestenol delta-isomerase activity(GO:0047750) |
0.2 | 1.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.2 | 2.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 1.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 2.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.2 | GO:0000035 | acyl binding(GO:0000035) |
0.2 | 2.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 0.6 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.2 | 1.1 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
0.2 | 1.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.6 | GO:0070815 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.6 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.2 | 0.8 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.2 | 0.6 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 7.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 6.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 8.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.8 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.2 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.2 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.9 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 1.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 2.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 7.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.2 | 4.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 6.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 8.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 5.2 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.2 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.2 | 3.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 2.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 2.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 1.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 0.7 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.2 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 9.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 1.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 0.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 2.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.6 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0004315 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) phosphopantetheine binding(GO:0031177) |
0.1 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.7 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.6 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
0.1 | 1.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 2.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 2.8 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.4 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.1 | 1.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 2.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
0.1 | 4.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 1.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.7 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 6.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 3.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0004877 | complement component C4b binding(GO:0001855) complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.4 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.1 | 1.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 1.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.6 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.7 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.1 | 0.4 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
0.1 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 4.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 2.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 1.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 1.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.7 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.1 | 1.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 3.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.2 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.1 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 10.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 1.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 14.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 2.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.1 | 1.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 1.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 0.4 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 1.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 2.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 3.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 3.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.3 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.1 | 0.3 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.1 | 1.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 1.5 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.5 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 3.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 2.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.3 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
0.1 | 1.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.9 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 0.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 1.6 | GO:0043295 | glutathione binding(GO:0043295) |
0.1 | 1.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.4 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 0.4 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.1 | 0.3 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
0.1 | 0.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 1.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 2.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 3.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.5 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.4 | GO:0030395 | lactose binding(GO:0030395) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 4.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 2.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 1.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 0.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 1.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 2.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 10.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 2.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 9.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.2 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.3 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.6 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 2.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 3.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.1 | 0.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 2.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 12.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 4.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.3 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.1 | 0.7 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 5.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 1.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.1 | GO:0070404 | NADH binding(GO:0070404) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 0.2 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.1 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 2.9 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 25.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.5 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 3.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 6.5 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.2 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 1.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 4.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.5 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 1.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 1.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 0.3 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.0 | 0.2 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.0 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 3.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 1.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.2 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 16.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.0 | 0.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.0 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 6.5 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.8 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 2.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.8 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 1.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.4 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 3.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 2.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 5.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 3.0 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.1 | GO:0047888 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 1.4 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 1.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 3.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 0.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.0 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 3.5 | GO:0005198 | structural molecule activity(GO:0005198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 46.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 17.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 10.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 3.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 5.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 10.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 5.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 4.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 9.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 5.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 9.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 12.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 8.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 11.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 12.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 12.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 5.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 55.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 3.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 5.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 4.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 38.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.8 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 3.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 3.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 4.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 3.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 4.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 4.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 3.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 2.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 4.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 2.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 10.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 10.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 9.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 14.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 7.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 1.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 6.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 1.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 8.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 4.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 11.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 9.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 14.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 4.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 6.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 12.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 6.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 4.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 14.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 4.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 5.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 3.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 5.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 4.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 7.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 3.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 6.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 4.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 9.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 2.1 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 5.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.3 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 2.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 6.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 3.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 8.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 4.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 2.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 5.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 3.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 3.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 4.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 2.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 3.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 3.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 3.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 3.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 2.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 6.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 4.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 3.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.4 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 1.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 14.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 4.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 9.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 3.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 2.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 6.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 6.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.9 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 1.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 1.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 2.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 2.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 3.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 2.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.8 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |